ENT Partners Appoints Tom Klise as Chief Financial Officer
ENT Partners Appoints Tom Klise as Chief Financial Officer
PR Newswire
SKOKIE, Ill., Nov. 18, 2026
SKOKIE, Ill., Nov. 18, 2026 /PRNewswire/ -- ENT Partners, a leading provider of ear, nose and throat (ENT) and related specialty healthcare services, today announced the appointment of Tom Klise as Chief Financial Officer (CFO). Klise brings extensive financial and operational leadership experience across multi-site healthcare organizations, including private equity-backed businesses.

In his new role, Klise will oversee ENT Partners' financial strategy and operations, with a focus on strengthening financial performance, enhancing operational efficiencies and supporting the organization's continued growth.
"Tom brings an exceptional combination of strategic financial expertise, operational leadership and deep experience in multi-site healthcare," said Jim Feinstein, Chief Executive Officer of ENT Partners. "His proven ability to strengthen financial operations, improve performance and support organizations through periods of growth makes him an outstanding addition to our leadership team. We are excited to welcome Tom as we continue to expand our platform and support the success of our physicians and practices."
Throughout his career, Klise has held senior financial leadership positions at several healthcare organizations, including Autism Home Support Services, Familia Dental, Imagen Dental Partners, Altius Dental and Ambulatory Anesthesia Solutions. His experience spans financial planning and analysis, revenue cycle management, cash flow optimization, operational improvement, acquisitions and strategic transactions.
Klise has a demonstrated track record of strengthening financial reporting and accounting infrastructure, improving collections and revenue cycle performance, and partnering with executive leadership teams to drive profitability and sustainable growth.
"I am excited to join ENT Partners at such an important stage in the organization's growth," said Klise. "I look forward to working alongside Jim and the leadership team to strengthen our financial capabilities, support our physician partners and build on the organization's success."
Klise holds an MBA from Northwestern University's Kellogg School of Management and a bachelor's degree in business with a concentration in finance from Miami University. He also serves on the board of a local nonprofit organization dedicated to supporting youth mental well-being.
ENT Partners is dedicated to supporting physicians in delivering comprehensive ENT patient care while promoting practice growth by alleviating administrative burdens and operational distractions. ENT Partners assists practices of all sizes from solo practitioners to large groups through a wide range of consulting services. ENT Partner practices are located across 23 sites in the Midwest and East Coast.

SOURCE ENT Partners

The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular

5 Stocks to Buy After Earnings

7 Undervalued Stocks That Crushed Earnings

This Newly Undervalued Stock Has Plenty of Growth Ahead

Are These Riskier Bond ETFs Worth the Higher Yields?

